Stay updated on ARO-C3 in Renal Disease Clinical Trial
Sign up to get notified when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.

Latest updates to the ARO-C3 in Renal Disease Clinical Trial page
- Check4 days agoChange DetectedThe page now reflects a new “Certification/Extension First Submitted” date (2026-04-21) and an updated site revision version (v3.5.3) instead of v3.5.2. This reflects administrative/technical record updating rather than altering the study details shown.SummaryDifference0.2%

- Check12 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded 'IgA glomerulonephritis' to the list of conditions on the study page.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded 'Complement 3 glomerulopathy' as a condition term and removed 'Non-immunoglobulin-mediated membranoproliferative glomerulonephritis' from the disease terminology.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows a revision note for v3.5.0. The previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to ARO-C3 in Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.